How China Lost the Covid War Nov. 28, 2022 Ironically,

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks Goosebumps #96309
312
How China Lost the Covid War
Nov. 28, 2022

Ironically, in the United States the politicians whose dogmatism most resembles that of Chinese leaders are right-wing Republicans. China has rejected foreign mRNA vaccines, despite clear evidence of their superiority; many Republican leaders have rejected vaccines in general, even in the face of a huge partisan divide in death rates linked to differential vaccination rates. This contrasts with Democrats, who have in general followed something like New Zealand’s approach, if much less effectively — restrictions early on, relaxed as vaccination spread.


Credit...Thomas Peter/Reuters

By Paul Krugman

Opinion Columnist

Do you remember when Covid was going to establish China as the world’s dominant power? As late as mid-2021, my inbox was full of assertions that China’s apparent success in containing the coronavirus showed the superiority of the Chinese system over Western societies that, as one commentator put it, “did not have the ability to quickly organize every citizen around a single goal.”

At this point, however, China is flailing even as other nations are more or less getting back to normal life. It’s still pursuing its zero-Covid policy, enforcing draconian restrictions on everyday activities every time new cases emerge. This is creating immense personal hardship and cramping the economy; cities under lockdown account for almost 60 percent of China’s G.D.P.

In early November many workers reportedly fled the giant Foxconn plant that produces iPhones, fearing not just that they would be locked in but that they would go hungry. And in the last few days many Chinese, in cities across the nation, have braved harsh repression to demonstrate against government policies.

I’m not a China expert, and I have no idea where this is going. As far as I can tell, actual China experts don’t know, either. But I think it’s worth asking what lessons we can draw from China’s journey from would-be role model to debacle.

Crucially, the lesson is not that we shouldn’t pursue public health measures in the face of a pandemic. Sometimes such measures are necessary. But governments need to be able to change policy in the face of changing circumstances and new evidence.

And what we’re seeing in China is the problem with autocratic governments that can’t admit mistakes and won’t accept evidence they don’t like.

In the first year of the pandemic, strong, even draconian restrictions made sense. It was never realistic to imagine that mask mandates and even lockdowns could prevent the coronavirus from spreading. What they could do, however, was slow the spread.

At first, the goal in the U.S. and many other countries was to “flatten the curve,” avoiding a peak in cases that would overwhelm the health care system.
Then, once it became clear that effective vaccines would become available, the goal was or should have been to delay infections until widespread vaccination could provide protection.

You could see this strategy at work in places like New Zealand and Taiwan, which initially imposed stringent rules that held cases and deaths to very low levels, then relaxed these rules once their populations were widely vaccinated.

Even with vaccines, opening up led to a large rise in cases and deaths — but not nearly as severe as would have happened if these places had opened up earlier, so that overall deaths per capita have been far lower than in the United States.

China’s leaders, however, seem to have believed that lockdowns could permanently stomp out the coronavirus, and they have been acting as if they still believe this even in the face of overwhelming contrary evidence.

At the same time, China utterly failed to develop a Plan B. Many older Chinese — the most vulnerable group — still aren’t fully vaccinated. China has also refused to accept foreign-made vaccines without unreasonable conditions that were rejected by the manufacturers, even though its homegrown vaccines, which don’t use mRNA technology, are less effective than the shots the rest of the world is getting.

All of this leaves Xi Jinping’s regime in a trap of its own making. The zero-Covid policy is obviously unsustainable, but ending it would mean tacitly admitting error, which autocrats never find easy. Furthermore, loosening the rules would mean a huge spike in cases and deaths.

Not only have many of the most vulnerable Chinese remained unvaccinated or received inferior shots, but because the coronavirus has been suppressed, few Chinese have natural immunity, and the nation also has very few intensive care beds, leaving it without the capacity to deal with a Covid surge.

It’s a nightmare, and nobody knows how it ends. But what can the rest of us learn from China?

First, autocracy is not, in fact, superior to democracy. Autocrats can act quickly and decisively, but they can also make huge mistakes because nobody can tell them when they’re wrong. At a fundamental level there’s a clear resemblance between Xi’s refusal to back off zero Covid and Vladimir Putin’s disaster in Ukraine.

Second, we’re seeing why it’s important for leaders to be open to evidence and be willing to change course when they’ve been proved wrong.

Ironically, in the United States the politicians whose dogmatism most resembles that of Chinese leaders are right-wing Republicans. China has rejected foreign mRNA vaccines, despite clear evidence of their superiority; many Republican leaders have rejected vaccines in general, even in the face of a huge partisan divide in death rates linked to differential vaccination rates. This contrasts with Democrats, who have in general followed something like New Zealand’s approach, if much less effectively — restrictions early on, relaxed as vaccination spread.

In short, what we can learn from China is broader than the failure of specific policies; it is that we should beware of would-be autocrats who insist, regardless of the evidence, that they’re always right.


https://www.nytimes.com/2022/11/28/opinion/ch...cracy.html
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Smart Salary Moves for S Corp Owners: Riggs Unpacks Insights

Updated Category News Views 192

Decoding the S Corp Salary Dance How much salary should the savvy owners of S corporations draw? It ain't a simple task or one-size-fits-all deal, folks. David Riggs spills the beans on HelloNation, sharing insights on this complex tango between drawing wages and raking in shareholder distributions. In the end, it’s about playing by the IRS rules—or risking a penalty...

Continue Reading
OlloBot's Emotional AI Robots Connect Beyond Tasks

Updated Category News Views 358

OlloBot Eyes Emotional Bonds, Not Just Robotics Power Is it just me, or is OlloBot onto something deep with their emotional AI companions? They've set a course that might just redefine how we perceive home robotics. At IFA Berlin 2026, they didn't just strut their technical stuff. Nope, they took it beyond gears and gadgets, turning heads with a robot that does more than...

Continue Reading
Abbott's SonicForce Impresses in Crucial Clinical Trial

Updated Category News Views 0

Breaking Through Cardiac Barriers Never thought I'd see the day when we're literally sending shockwaves through the heart, but here we are. Abbott's makin' waves, quite literally, with its SonicForce™ Coronary Intravascular Lithotripsy (IVL) System. They’ve just dropped some promising 30-day outcomes from the TECTONIC study, which has grabbed the spotlight at the...

Continue Reading
Navigating Underinsured Motorist Coverage Woes

Updated Category News Views 109

When the Rubber Hits the Road: Coverage Gaps Ever been in a fender bender and found out the other driver’s insurance barely covers a dent, let alone a serious crash? Believe me, it's no picnic. Chuck Clark from HelloNation digs into this with a deep dive on underinsured motorist coverage, or UIM for short. It's an eye-opener—especially if you're assuming your auto...

Continue Reading
Dutch Bros Pours Holiday Cheer with New Festive Menu

Updated Category News Views 145

New Festive Offerings from Dutch Bros Kicking off the holiday season with a splash of vibrant flavors, Dutch Bros is shaking up the menu with some fresh, festive entries. Two new drink concoctions hit the stage alongside a themed delectable treat, and for those traditionalists, perennial favorites make a triumphant return. Dutch Bros Expands Its Vibrant Lineup It's not...

Continue Reading
Termite Swarmers: Essential Clues and Action Steps

Updated Category News Views 144

Understanding the Intrusive Nature of Termite Swarmers When it comes to creepy crawlies wreaking havoc on your beloved abode, termites are the stealthy troublemakers you need to keep an eye out for. Just because you catch a glimpse of them doesn't mean the damage is obvious or minimal. Spotting the Culprits: Termites vs. Ants Identifying what you're up against is the...

Continue Reading
Brigham Nurses Dig In for Strike: Fight for Fairness

Updated Category News Views 49

Strike Looms as Brigham Nurses Demand Fair Treatment Massachusetts is gearing up for its largest open-ended nursing strike in history as Brigham and Women's Hospital nurses prepare to lay down their tools in pursuit of a just contract. This ain't your typical workplace squabble; it's a full-blown battle for patient safety and professional respect. The Core Grievances at...

Continue Reading
Perion Acquisition: Affle's Bold Leap in Ad Tech

Updated Category News Views 57

Affle's Strategic Acquisition of Perion Jumpin' through another hoop, Affle is gearing up to snag Perion in a hefty deal valued at about $420 million. For those of you not knee-deep in the ad tech sandbox, Affle—trading on the NSE as AFFLE—is aiming to ramp up its AI-driven conversion game by absorbing Perion, a veteran in the omnichannel advertising realm. "This...

Continue Reading
Aiper’s Black Friday Pool Deals Make a Splash

Updated Category News Views 120

Black Friday: A Pool Owner's Break It’s not every day you stumble upon savings like these—Aiper is throwing some meaty discounts this Black Friday, saving pool owners up to a juicy $550 off robotic cleaners. Imagine that! For anyone with a pool to maintain, these deals might just be the ticket to less grunt work and more time lounging with a cold drink in hand....

Continue Reading
SICO Snags $1.6B in New Investor Mandates for 2026

Updated Category News Views 68

SICO Makes Waves with Massive New Business Wins Right out of the gate at the Gateway Gulf 2026 Forum, SICO's announcement of a whopping $1.6 billion in new business mandates had even the seasoned pros raising an eyebrow or two. There's nothing like a sweet billion-dollar figure to kickstart the day, huh? This isn't small change we're talking about; this is a tidal wave of...

Continue Reading

Top 5 Most Recently Viewed Articles

111, Inc. Reports Strategic Q1 2026 Financial Shift

Updated Category News Views 32

Reinventing the Wheel: 111, Inc.'s Financial Upheaval Savvy investors, take note: 111, Inc. (NASDAQ:YI) just lobbed a financial curveball, waving their first quarter 2026 results like a bullfighter's cape. The spectacle? Revenues sliding downhill by over 33% to RMB2.4 billion (US$342.4 million). You might be tempted to scribble this off as a snooze, but the company's...

Continue Reading
Revolutionizing Commerce: Seamless Checkout within Chat Platforms

Updated Category News Views 225

Transforming the Shopping Experience with Innovative Commerce As social commerce trends continue to evolve, we anticipate a market that could very well reach an astonishing $2 trillion soon. In this landscape, Mind Over Media and Skipify have joined forces to create a groundbreaking Checkout-in-Chat service. This initiative allows customers to explore, make decisions, and...

Continue Reading
Long-Term US-Israel Security Pact Proposed for Future Stability

Updated Category News Views 169

Israel Proposes a New Security Agreement with the United States Israel is actively pursuing a substantial 20-year security agreement with the United States. This initiative includes provisions reflecting an 'America First' approach to enhance collaboration and support from the current U.S. administration. The goal is to solidify a long-term partnership to navigate complex...

Continue Reading
Certara Sets Date for Third Quarter Financial Report Release

Updated Category News Views 132

Certara Announces Financial Results Meeting Certara, Inc. (NASDAQ: CERT), a global leader in biosimulation, is gearing up to share its third quarter financial performance for 2025. The announcement comes as part of the company's commitment to transparency and investor engagement. Conference Call Details Scheduled for Thursday, November 6, 2025, Certara plans to release...

Continue Reading
Swissmedic Grants Approval for New IgA Nephropathy Treatment

Updated Category News Views 154

Switzerland Approves Innovative Treatment for IgA Nephropathy In a significant advancement for kidney health, CSL Vifor and Travere Therapeutics, Inc. (NASDAQ: TVTX) have announced that the Swiss regulatory authority, Swissmedic, has granted temporary marketing authorization for FILSPARI (sparsentan). This approval marks a crucial step forward in the treatment of IgA...

Continue Reading